TY  - GEN
AU  - Luis Izquierdo, Jose
AU  - García-Cosío, Borja
PY  - 2018
DO  - 10.2147/COPD.S175047
SN  - 1178-2005
UR  - https://hdl.handle.net/20.500.12105/22626
AB  - Background: The use of inhaled corticosteroids (ICS) in combination with bronchodilators in patients with COPD has been shown to decrease the rate of disease exacerbations and to improve the lung function and patients' quality of life. However, their...
LA  - eng
PB  - Dove Medical Press
KW  - Acute exacerbations
KW  - Anti-inflammatory effects
KW  - COPD
KW  - Asthma-COPD overlap syndrome
KW  - Inhaled corticosteroids
KW  - lOwer doses of ICS
KW  - Pneumonia
KW  - Lung
KW  - Quality of Life
KW  - Administration, Inhalation
KW  - Dose-Response Relationship, Drug
KW  - Adrenal Cortex Hormones
KW  - Risk Factors
KW  - Pulmonary Disease, Chronic Obstructive
KW  - Treatment Outcome
KW  - Humans
KW  - Recovery of Function
KW  - Pneumonia
KW  - Incidence
TI  - The dose of inhaled corticosteroids in patients with COPD: when less is better
TY  - review article
ER  -